| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 642 |
| 1 | RANITIDINE | 551 |
| 2 | METHOTREXATE SODIUM | 531 |
| 3 | ETANERCEPT | 485 |
| 4 | ASPIRIN | 482 |
| 5 | METHOTREXATE | 472 |
| 6 | ASPIRIN 325 MG | 452 |
| 7 | ASPIRIN 81 MG | 452 |
| 8 | INFLIXIMAB | 444 |
| 9 | RANITIDINE HYDROCHLORIDE | 391 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRUQUINTINIB | 371 | 0.0984 |
| 1 | REGORAFENIB | 344 | 0.0298 |
| 2 | VADADUSTAT | 7 | 0.0246 |
| 3 | PANITUMUMAB | 267 | 0.0171 |
| 4 | SODIUM IODIDE I 123 | 11 | 0.0117 |
| 5 | SODIUM IODIDE I 131 | 11 | 0.0115 |
| 6 | LEVOLEUCOVORIN INJECTION | 33 | 0.0111 |
| 7 | DAPRODUSTAT | 20 | 0.0106 |
| 8 | IRINOTECAN HYDROCHLORIDE | 122 | 0.0095 |
| 9 | LEVOLEUCOVORIN | 35 | 0.0094 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1051 |
| 1 | Corticosteroid [EPC] | 937 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 919 |
| 3 | Histamine-2 Receptor Antagonist [EPC] | 676 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 507 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 499 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 473 |
| 7 | Proton Pump Inhibitor [EPC] | 456 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 436 |
| 9 | Loop Diuretic [EPC] | 425 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 24 | 0.0113 |
| 1 | Photoactivated Radical Generator [EPC] | 1 | 0.0081 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 316 | 0.0068 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0032 |
| 4 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 13 | 0.0025 |
| 5 | Tyrosine Kinase 2 Inhibitor [EPC] | 7 | 0.0025 |
| 6 | Non-Standardized Fungal Allergenic Extract [EPC] | 5 | 0.0024 |
| 7 | Chloride Channel Activator [EPC] | 22 | 0.0023 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 676 | 0.0021 |